These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2666666)

  • 1. Synthesis of acyclonucleoside hydroxamic acids as inhibitors of ribonucleotide reductase.
    Farr RA; Bey P; Sunkara PS; Lippert BJ
    J Med Chem; 1989 Aug; 32(8):1879-85. PubMed ID: 2666666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivatives.
    Elford HL; van't Riet B
    Pharmacol Ther; 1985; 29(2):239-54. PubMed ID: 3939037
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents.
    Elford HL; Van't Riet B; Wampler GL; Lin AL; Elford RM
    Adv Enzyme Regul; 1980; 19():151-68. PubMed ID: 6175187
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity.
    van't Riet B; Wampler GL; Elford HL
    J Med Chem; 1979 May; 22(5):589-92. PubMed ID: 458812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active site of ribonucleoside diphosphate reductase from Escherichia coli. Inactivation of the enzyme by 2'-substituted ribonucleoside diphosphates.
    Thelander L; Larsson B
    J Biol Chem; 1976 Mar; 251(5):1398-405. PubMed ID: 767333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.
    Cory JG; Sato A; Lasater L
    Adv Enzyme Regul; 1980; 19():139-50. PubMed ID: 7039256
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis, cytostatic activity and inhibition of ribonucleotide reductase by 5'-phosphoramidates and 5'-diphosphates, of 2'-O-allyl-arabinofuranosyl nucleosides.
    Manfredini S; Baraldi PG; Durini E; Balzarini J; De Clercq E; Karlsson A; Buzzoni V; Thelander L
    Nucleosides Nucleotides; 1999; 18(4-5):1007-8. PubMed ID: 10432732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy.
    Szekeres T; Fritzer-Szekeres M; Elford HL
    Crit Rev Clin Lab Sci; 1997; 34(6):503-28. PubMed ID: 9439883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative analysis of steric and hydrophobic effects in ribonucleoside diphosphate reductase inhibition by thiosemicarbazones.
    Gupta SP; Prabhakar YS; Bindal MC; Handa A
    Arzneimittelforschung; 1984; 34(2):147-50. PubMed ID: 6372802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Products of the inactivation of ribonucleoside diphosphate reductase from Escherichia coli with 2'-azido-2'-deoxyuridine 5'-diphosphate.
    Salowe SP; Ator MA; Stubbe J
    Biochemistry; 1987 Jun; 26(12):3408-16. PubMed ID: 3307907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of benzohydroxamic acid inhibitors of ribonucleotide reductase.
    van't Riet B; Kier LB; Elford HL
    J Pharm Sci; 1980 Jul; 69(7):856-7. PubMed ID: 6993654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanisms of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime.
    Tihan T; Elford HL; Cory JG
    Adv Enzyme Regul; 1991; 31():71-83. PubMed ID: 1877400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).
    Moore EC; Hurlbert RB
    Pharmacol Ther; 1985; 27(2):167-96. PubMed ID: 3898152
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of inactivation of Escherichia coli ribonucleotide reductase by 2'-chloro-2'-deoxyuridine 5'-diphosphate: evidence for generation of a 2'-deoxy-3'-ketonucleotide via a net 1,2 hydrogen shift.
    Ator MA; Stubbe J
    Biochemistry; 1985 Dec; 24(25):7214-21. PubMed ID: 3910098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New ribonucleotide reductase inhibitors with antineoplastic activity.
    Elford HL; Wampler GL; van't Riet B
    Cancer Res; 1979 Mar; 39(3):844-51. PubMed ID: 427774
    [No Abstract]   [Full Text] [Related]  

  • 16. The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
    Cory JG; Sato A; Carter GL; Bacon PE; Montgomery JA; Brown NC
    Adv Enzyme Regul; 1985; 23():181-92. PubMed ID: 3907303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine (NSC 118994) and inosinic acid.
    Cory JG; Mansell MM; Whitford TW
    Cancer Res; 1976 Sep; 36(9 pt.1):3166-70. PubMed ID: 987850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
    Sato A; Bacon PE; Cory JG
    Adv Enzyme Regul; 1984; 22():231-41. PubMed ID: 6089512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone.
    Turk SR; Shipman C; Drach JC
    Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mammalian ribonucleotide reductase by a dinucleotide produced in eucaryotic cells.
    Lewis WH; McNaughton DR; Goh SH; LéJohn HB; Wright JA
    J Cell Physiol; 1977 Dec; 93(3):345-52. PubMed ID: 338619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.